<DOC>
	<DOCNO>NCT01017549</DOCNO>
	<brief_summary>The purpose multi-center clinical study compile post market performance safety data Axxent System .</brief_summary>
	<brief_title>Post Market Study Using Xoft Axxent System</brief_title>
	<detailed_description>The purpose multi-center clinical study compile post market performance safety data Axxent System delivery radiation therapy part breast conserve therapy woman resect , early stage breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Age &gt; 50 year Tumor Tis , T1 , N0 , M0 ( AJC Classification ) Invasive ductal carcinoma ductal carcinoma situ Negative microscopic surgical margin least 1mm direction Adequate skin space balloon surface surface skin ( &gt; 7mm ) Pregnancy breastfeed ( During treatment portion study , sexually active woman childbearing age ask use pregnancy prevention ) Scleroderma , systemic sclerosis active lupus Infiltrating lobular histology</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Stage I</keyword>
	<keyword>Stage II</keyword>
	<keyword>Breast</keyword>
	<keyword>Cancer</keyword>
</DOC>